Form 4 for ANTX AN2 Therapeutics, Inc.

Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-29 · accession 0000899243-22-012992 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-31	2022-03-29	ANTX	Zakrzewski Joseph S	Dir	C - Cnv Deriv	—	+98.2K	98.2K	New	—
D	2022-03-31	2022-03-29	ANTX	Zakrzewski Joseph S	Dir	C - Cnv Deriv	$0.00	-98.2K	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-29	C	A	98,199	—	98,199	D	—	—	(F1) Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
2	Derivative	Series A Convertible Preferred Stock	2022-03-29	C	D	98,199	$0.00	0	D	— · — to —	98,199 Common Stock	(F1) Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.